Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, we wish to inform you that in continuation to our intimation dated 7th July, 2025, Company has received mandatory regulatory approval from the Food and Drug Authority, Gujarat for manufacturing and supply of personal care products for one of the India''s leading marketplace company.In addition to the regulatory approval, Company has also received its first commercial order for manufacture and supply of products in personal care category. This order is for products in skin care and face care segment and going forward more products would be added to the contract manufacturing portfolio.
Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order
Filed with BSE · · 3 pages · English
Release
Veerhealth Care Limited on 6ix
Earlier from Veerhealth Care
- Veerhealth Care Limited Press Release Jul 21 2025
- Veerhealth Care Limited Press Release Jul 09 2025
- Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Veerhealth Care Limited Press Release Jul 07 2025
- Announcement Under Regulation 30 (LODR) - Contract Manufacturing Agreement With Leading Marketplace Company
Later from Veerhealth Care
- Veerhealth Care Limited Press Release Jul 25 2025
- Updates
- Veerhealth Care Limited Press Release Jul 29 2025
- Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter Ended 30Th June, 2025.
- Veerhealth Care Limited Press Release Aug 01 2025
Follow Veerhealth Care into a list and get an email when it puts out news.
Follow Veerhealth Care